COVID-19: At least 427 million people go into lockdown in India
No community transmission but national lockdown most essential, says ICMR director-general
Coronavirus: Enough drug ingredients, says govt, refuses to go into detail
Union Health minister says India will not repatriate citizens stuck on ship in Japan
Guidelines released for evaluation of nano drugs
Nano-pharmaceuticals are expected to be of great use particularly in cancer treatment
COVID-19: INSACOG shares genome sequencing data after a gap of 3 months
India sequenced 89,860 samples between January and April, according to the latest bulletin. The total is now 240,570 sequenced samples
COVID-19: Union health ministry issues guidelines for telemedicine
On SC’s direction to encourage less patient-doctor interaction. Registered medical practitioners will need to complete an online course first
Over 50 people die due to swine flu in just one month
As many as 1,036 people have tested positive between January 1 and 17, 2019 in Rajasthan, while 40 have died, according to sources in the state&…
India's rare diseases policy hangs in balance
A 10-member committee, formed to draft a revised policy, has not held a single meeting yet
Delhi HC quashes Centre’s ban on drug that helps women with childbirth
Oxytocin was earlier banned as it was being illegally given to cattle to increase milk production
Ventilators for COVID-19: Crisis looms in several states even after 50,000 allocated
More than 7,000 of the Centre-allocated ventilators are lying idle
All tuberculosis patients to be screened for COVID-19
Studies show up to 4.47% of COVID-19 patients have prevalence of tuberculosis
India reports 21 cases of COVID sub-variant JN.1, now a WHO ‘variant of interest’
We need to be on the alert, but there is no need to panic, says Union Health Minister Mansukh Mandaviya
Over half of prescribed antibiotics in India can lead to AMR, finds National Centre for Disease Control
High use of antibiotics found; recommends defined policies and monitoring consumption
NITI Aayog health index: Kerala maintains top spot
The worst-performing state in overall performance was Uttar Pradesh; Bihar, Madhya Pradesh performed marginally better
Coronavirus update: Has India got its first COVID-19 reinfection case
Doctors at Ahmedabad private hospital claim 54-year-old woman has retested positive for COVID-19
New ruse in Big Pharma's old game
Drug multinationals are lobbying for a devious patent linkage system to block the entry of competitive generics
India in talks with Russia on ‘unverified’ COVID-19 vaccine
Indian serostudies do not talk about neutralising antibodies, says ICMR DG
Govt neither denies nor accepts adverse event in Serum Institute COVID-19 vaccine trial
Health secretary claims all procedures followed but refuses to divulge details
COVID-19 Vaccine Watch: Appeals made for support on proposal regarding intellectual property
If it is adopted on December 16, IP rights on production and supply of COVID-19 tools will be waived off
CAG report finds promotion irregularities at ICMR institute
Irregular payments of over Rs 2 crore at NICED; Promotions ante-dated by upto 34 months
Ban on pesticides: Plea in Supreme Court alleges restriction on reduced number of chemicals to protect companies
Next hearing on April 28; SC seeks reasons for the decision from Centre
As told to Parliament (February 12, 2021): CSE expose on honey adulteration taken note of by Centre
All that was discussed in the House through the day
Ivermectin for COVID-19: Mismatch between global and Indian policies
Union health ministry guidelines say the drug "may be" used for COVID-19 patients even as global agencies don't recommend
Don’t doubt India’s drug regulator on COVID-19 vaccines: Government
Weekly press meeting also releases details of COVID-19 vaccination; healthcare and frontline workers, seniors to be immunised on priority basis
10 years of Delhi gang rape: 70% of released Nirbhaya Funds utilised, Lok Sabha told
Region-wise disparities in fund utilisation; Conviction rate in crimes against women continues to remain abysmal
Decision on emergency authorisation for SII, Bharat Biotech’s COVID-19 vaccines deferred
Both manufacturers have been asked for more data before a final decision can be reached